https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2010-07-29 12:23:542016-11-28 12:24:19Astex scientists describe novel HSP90 inhibitors in two key publications in Journal of Medicinal Chemistry
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2010-06-30 12:24:282016-11-28 12:24:57Dacogen® (Decitabine) for Injection Phase III AML Results Announced
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2010-06-02 12:25:112016-11-28 12:25:39Encouraging Interim Data From A Phase I Study Of Astex’s HSP90 Inhibitor AT13387 To Be Presented At ASCO
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2010-04-13 12:26:252016-11-28 12:26:48Encouraging data from three Astex collaborative programmes to be presented at the 101st American Association for Cancer Research (AACR) Annual Meeting 2010
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2010-02-09 12:27:302016-11-28 12:27:51Astex Executive Receives the AstraZeneca Business Development Professional of the Year 2009 Award
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2010-01-07 12:28:012016-11-28 12:28:22Clinical Candidate From PKB/AKT Collaboration With Astex Selected by AstraZeneca